TITLE

Potential of Human Embryonic Stem Cells in Cartilage Tissue Engineering and Regenerative Medicine

AUTHOR(S)
Toh, Wei; Lee, Eng; Cao, Tong
PUB. DATE
September 2011
SOURCE
Stem Cell Reviews & Reports;Sep2011, Vol. 7 Issue 3, p544
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The current surgical intervention of using autologous chondrocyte implantation (ACI) for cartilage repair is associated with several problems such as donor site morbidity, de-differentiation upon expansion and fibrocartilage repair following transplantation. This has led to exploration of the use of stem cells as a model for chondrogenic differentiation as well as a potential source of chondrogenic cells for cartilage tissue engineering and repair. Embryonic stem cells (ESCs) are advantageous, due to their unlimited self-renewal and pluripotency, thus representing an immortal cell source that could potentially provide an unlimited supply of chondrogenic cells for both cell and tissue-based therapies and replacements. This review aims to present an overview of emerging trends of using ESCs in cartilage tissue engineering and regenerative medicine. In particular, we will be focusing on ESCs as a promising cell source for cartilage regeneration, the various strategies and approaches employed in chondrogenic differentiation and tissue engineering, the associated outcomes from animal studies, and the challenges that need to be overcome before clinical application is possible.
ACCESSION #
62806328

 

Related Articles

  • Strategies for enrichment and selection of stem cell-derived tissue precursors. Bernstein, Harold S.; Hyun, William C. // Stem Cell Research & Therapy;2012, Vol. 3 Issue 3, p1 

    Human embryonic stem cells have the capacity for self-renewal and pluripotency and thus are a primary candidate for tissue engineering and regenerative therapies. These cells also provide an opportunity to study the development of human tissues ex vivo. To date, numerous human embryonic stem...

  • Human stem cell research and regenerative medicine—present and future. Volarevic, Vladislav; Ljujic, Biljana; Stojkovic, Petra; Lukic, Aleksandra; Arsenijevic, Nebojsa; Stojkovic, Miodrag // British Medical Bulletin;Sep2011, Vol. 99 Issue 1, p155 

    Introduction Stem cells are cells with the ability to grow and differentiate into more than 200 cell types. Sources of data We review here the characteristics and potential of human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs). Areas of...

  • Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation. Lázaro, I.; Kostarelos, K. // Stem Cell Reviews & Reports;Feb2016, Vol. 12 Issue 1, p129 

    Changes in cell identity occur in adult mammalian organisms but are rare and often linked to disease. Research in the last few decades has thrown light on how to manipulate cell fate, but the conversion of a particular cell type into another within a living organism (also termed in vivo...

  • Regulatory Influence of Scaffolds on Cell Behavior: How Cells Decode Biomaterials. Pennesi, G.; Scaglione, S.; Giannoni, P.; Quarto, R. // Current Pharmaceutical Biotechnology;Feb2011, Vol. 12 Issue 2, p151 

    No abstract available.

  • Biology of Mesenchymal Stem Cells. Jakob, Franz; Limbert, Catarina; Schilling, Tatjana; Benisch, Peggy; Seefried, Lothar; Eber, Regina // Current Rheumatology Reviews;2008, Vol. 4 Issue 3, p148 

    Mesenchymal stem cells (MSC) are derived from mesodermal precursor and are committed towards mesenchymal differentiation. They are scattered all over the organism, situated in bone, cartilage, adipose tissue and accompany organs for tissue regeneration and structural and functional support. MSC...

  • Umbilical Cord Blood: A Unique Source of Pluripotent Stem Cells for Regenerative Medicine. Harris, David T.; Rogers, Ian // Current Stem Cell Research & Therapy;Dec2007, Vol. 2 Issue 4, p301 

    It is estimated that almost 1 in 3 individuals in the United States might benefit from regenerative medicine therapy. Unfortunately, embryonic stem (ES) cell therapies are currently limited by ethical, political, biological and regulatory hurdles. Thus, for the foreseeable future, the march of...

  • In vitro morphological bud formation in organ-like three-dimensional structure from mouse ES cells induced by FGF10 signaling. Ohbuchi, Toyoaki; Takaki, Miyako; Misawa, Hiromi; Suzuki, Hideaki; Ueta, Yoichi // Communicative & Integrative Biology;Jul2012, Vol. 5 Issue 4, p312 

    Embryonic stem (ES) cells have a pluripotent ability to differentiate into a variety of cell lineages in vitro. Using an embryoid body (EB) culture system, we developed a gut-like three-dimensional structure from mouse ES cells (the ES 3-D structure). Genetic studies implicate fibroblast growth...

  • Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Cananzi, Mara; Atala, Anthony; De Coppi, Paolo // Reproductive BioMedicine Online (Reproductive Healthcare Limited;2009 Supplement 1, Vol. 18 Issue S1, p17 

    Human amniotic fluid cells have been used as a diagnostic tool for the prenatal diagnosis of fetal genetic anomalies for more than 50 years. Evidence provided in the last 5 years, however, suggests that they can also harbour a therapeutic potential for human diseases, as different populations of...

  • Cell Approaches in Renal Tissue Engineering. Aboushwareb, Tamer // UroToday International Journal;2010, Vol. 3 Issue 6, p1 

    Renal regenerative therapy is an exceedingly complex endeavor due to the multiple functions of the kidney. There is a shortage of donor kidneys and more patients are now progressing to end-stage renal disease, so a significant clinical application from this research is urgently needed. Renal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics